132 related articles for article (PubMed ID: 16222360)
1. Long-acting inhaled bronchodilators for COPD--lack of logic continues.
Jones D
N Z Med J; 2005 Sep; 118(1222):U1669. PubMed ID: 16222360
[TBL] [Abstract][Full Text] [Related]
2. PHARMAC responds on long-acting inhalers for COPD.
Metcalfe S; Dougherty S
N Z Med J; 2005 Nov; 118(1225):U1743. PubMed ID: 16286950
[No Abstract] [Full Text] [Related]
3. [Triple therapy in chronic obstructive pulmonary disease].
Baloira A
Arch Bronconeumol; 2010; 46 Suppl 8():25-30. PubMed ID: 21334553
[TBL] [Abstract][Full Text] [Related]
4. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)].
Szmidt M
Pneumonol Alergol Pol; 2012; 80(3):255-62. PubMed ID: 22562275
[TBL] [Abstract][Full Text] [Related]
5. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
Gordon E; Lazarus SC
J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
[TBL] [Abstract][Full Text] [Related]
7. Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease.
Nichols J
Pharmacotherapy; 2007 Mar; 27(3):447-54. PubMed ID: 17316155
[TBL] [Abstract][Full Text] [Related]
8. [Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease].
Pedersen ST
Ugeskr Laeger; 2005 Jun; 167(23):2504-6. PubMed ID: 16008004
[No Abstract] [Full Text] [Related]
9. Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD.
Najafzadeh M; Marra CA; Sadatsafavi M; Aaron SD; Sullivan SD; Vandemheen KL; Jones PW; Fitzgerald JM
Thorax; 2008 Nov; 63(11):962-7. PubMed ID: 18621985
[TBL] [Abstract][Full Text] [Related]
10. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA; Donohue JF
Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
[TBL] [Abstract][Full Text] [Related]
11. Triple inhalers for obstructive airways disease: will they be useful?
Barnes PJ
Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
[No Abstract] [Full Text] [Related]
12. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
13. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
Tashkin DP; Hanania NA; McGinty J; Denis-Mize K; Chaudry I
Adv Ther; 2009 Nov; 26(11):1024-34. PubMed ID: 19953349
[TBL] [Abstract][Full Text] [Related]
14. Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study.
Dal Negro RW; Turati C; Micheletto C; Menegoni F
Ther Adv Respir Dis; 2012 Apr; 6(2):97-105. PubMed ID: 22250038
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
Wang J; Nie B; Xiong W; Xu Y
J Clin Pharm Ther; 2012 Apr; 37(2):204-11. PubMed ID: 21740451
[TBL] [Abstract][Full Text] [Related]
16. The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients.
Kim J; Kim K; Kim Y; Yoo KH; Lee CK; Yoon HK; Kim YS; Park YB; Lee JH; Oh YM; Lee SD; Lee SW
Respir Med; 2014 Jan; 108(1):153-61. PubMed ID: 23993445
[TBL] [Abstract][Full Text] [Related]
17. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L; Forget A; Ramachandran S
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[TBL] [Abstract][Full Text] [Related]
18. Managing chronic diseases: combination of inhaler treatment in India has shown good results.
Koul PA
BMJ; 2005 Apr; 330(7497):964; discussion 964-5. PubMed ID: 15845987
[No Abstract] [Full Text] [Related]
19. [Evidence of pharmacotherapy in COPD--key findings from recently-conducted randomized clinical studies].
Shimizu K; Nishimura M
Nihon Rinsho; 2011 Oct; 69(10):1815-20. PubMed ID: 22073579
[TBL] [Abstract][Full Text] [Related]
20. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.
Cazzola M; Noschese P; Salzillo A; De Giglio C; D'Amato G; Matera MG
Respir Med; 2005 May; 99(5):524-8. PubMed ID: 15823447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
